Biomedical applications of snake venom: from basic science to autoimmunity and rheumatology
Authors:
Open Access
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Journal of Translational Autoimmunity
- Vol. 4, 100076
Abstract
No abstract availableKeywords
Funding Information
- Asociación Colombiana de Reumatología
- Universidad ICESI
This publication has 168 references indexed in Scilit:
- Immune Response to Snake Envenoming and Treatment with Antivenom; Complement Activation, Cytokine Production and Mast Cell DegranulationPLOS Neglected Tropical Diseases, 2013
- Role of Collagens and Perlecan in Microvascular Stability: Exploring the Mechanism of Capillary Vessel Damage by Snake Venom MetalloproteinasesPLOS ONE, 2011
- Anti-metastatic activity of the recombinant disintegrin, r-mojastin 1, from the Mohave rattlesnakeToxicon, 2011
- Increased expression of vascular endothelin type B and angiotensin type 1 receptors in patients with ischemic heart diseaseBMC Cardiovascular Disorders, 2009
- Angiostatic activity of obtustatin as α1β1 integrin inhibitor in experimental melanoma growthInternational Journal of Cancer, 2008
- Pro‐ and Anti‐Inflammatory Cytokines Release in Mice Injected withCrotalus durissus terrificusVenomMediators of Inflammation, 2008
- The integrinsGenome Biology, 2007
- Afaâcytin, an αβ‐fibrinogenase from Cerastes cerastes (Horned Viper) Venom, Activates Purified Factor X and Induces Serotonin Release from Human Blood PlateletsEuropean Journal of Biochemistry, 1995
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Biochemistry and pharmacology of the crotoxin complexNaunyn-Schmiedeberg's Archives of Pharmacology, 1971